As assessed by ICC and IHC, primary CML cells expressed substantial amounts of BRD4 and MYC in most patients examined without major differences in staining intensity when comparing CP and BP samples (Figure 1A,B). Here, BRD4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.